speb/financial-data huggingface dataset:
UCB cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
UCB cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
UCB income_statement (quarterly, 2025-09-30) — Net Income: 91494000.00
UCB income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 86139000.00
UCB income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 91494000.00
UCB income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 91494000.00
UCB income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 91494000.00
UCB cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 91494000.00
UCB income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 91494000.00
UCB income_statement (quarterly, 2025-09-30) — Net Interest Income: 233629000.00
UCB cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 234233000.00
UCB cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
UCB cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
UCB cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 17000.00
UCB cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 7798000.00
UCB balance_sheet (quarterly, 2025-09-30) — Net PPE: 394536000.00
UCB cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -5386000.00
UCB cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 0.00
UCB balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 2625780000.00
UCB income_statement (quarterly, 2025-09-30) — Normalized Income: 94181700.00
UCB income_statement (quarterly, 2025-09-30) — Occupancy And Equipment: 25439000.00
UCB cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 123095000.00
UCB cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -2434000.00
UCB income_statement (quarterly, 2025-09-30) — Operating Revenue: 270877000.00
UCB balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 121553462.00
UCB balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 0.00
UCB balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -163923000.00
UCB balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 13683000.00
UCB balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 45952000.00
UCB income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 8829000.00
UCB balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 3889263000.00
UCB income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 507000.00
UCB balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
UCB cash_flow (quarterly, 2025-09-30) — Preferred Stock Dividend Paid: -1573000.00
UCB income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 4848000.00
UCB income_statement (quarterly, 2025-09-30) — Pretax Income: 118073000.00
UCB income_statement (quarterly, 2025-09-30) — Professional Expense And Contract Services Expense: 6282000.00
UCB cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -106846000.00
UCB cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -5386000.00
UCB income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 10784000.00
UCB cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
UCB cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -91541000.00
UCB income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 3468000.00
UCB balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 858395000.00
UCB income_statement (quarterly, 2025-09-30) — Salaries And Wages: 90667000.00
UCB cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 341079000.00
UCB income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 2053000.00
UCB income_statement (quarterly, 2025-09-30) — Selling General And Administration: 97566000.00
UCB balance_sheet (quarterly, 2025-09-30) — Share Issued: 121553462.00
UCB cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: 0.00
UCB income_statement (quarterly, 2025-09-30) — Special Income Charges: -3468000.00
UCB cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2969000.00
UCB balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 3596851000.00
UCB balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 2625780000.00
UCB income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -780300.00
UCB income_statement (quarterly, 2025-09-30) — Tax Provision: 26579000.00
UCB income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.23
UCB balance_sheet (quarterly, 2025-09-30) — Total Assets: 28143473000.00
UCB balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 3752102000.00
UCB balance_sheet (quarterly, 2025-09-30) — Total Debt: 155251000.00
UCB balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 3596851000.00
UCB balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 24546622000.00
UCB income_statement (quarterly, 2025-09-30) — Total Unusual Items: -3468000.00
UCB income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -3468000.00
UCB income_statement (annual, 2025-12-31) — +Total Revenue: 1040952000.00
UCB income_statement (quarterly, 2025-12-31) — +Total Revenue: 272809000.00
UCB balance_sheet (annual, 2025-12-31) — Accounts Receivable: 83557000.00
UCB balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 83557000.00
UCB balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -186531000.00
UCB balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -186531000.00
UCB balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 2754399000.00
UCB balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 2754399000.00
UCB income_statement (annual, 2025-12-31) — Amortization: 13079000.00
UCB income_statement (quarterly, 2025-12-31) — Amortization: 3188000.00
UCB income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 13079000.00
UCB income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 3188000.00
UCB cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
UCB cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
UCB balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 831623000.00
UCB balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 831623000.00
UCB income_statement (annual, 2025-12-31) — Basic Average Shares: 121309000.00
UCB income_statement (quarterly, 2025-12-31) — Basic Average Shares: 121672000.00
UCB income_statement (annual, 2025-12-31) — Basic EPS: 2.62
UCB income_statement (quarterly, 2025-12-31) — Basic EPS: 0.71
UCB cash_flow (annual, 2025-12-31) — Beginning Cash Position: 519873000.00
UCB cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 613431000.00
UCB balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 308810000.00
UCB balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 308810000.00
UCB cash_flow (annual, 2025-12-31) — Capital Expenditure: -27579000.00
UCB cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -5759000.00
UCB balance_sheet (annual, 2025-12-31) — Capital Stock: 120598000.00
UCB balance_sheet (quarterly, 2025-12-31) — Capital Stock: 120598000.00
UCB balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 395754000.00
UCB balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 395754000.00
UCB balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 395754000.00
UCB balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 395754000.00
UCB cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -123237000.00
UCB cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -30841000.00
UCB balance_sheet (annual, 2025-12-31) — Cash Financial: 202586000.00
UCB balance_sheet (quarterly, 2025-12-31) — Cash Financial: 202586000.00
UCB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -541571000.00
UCB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -232986000.00
UCB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 33417000.00
UCB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -50163000.00
UCB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 384035000.00
UCB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 65472000.00
UCB cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -12737000.00
UCB cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -29611000.00
UCB cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -58276000.00
UCB cash_flow (annual, 2025-12-31) — Change In Working Capital: -52860000.00
UCB cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -56349000.00
UCB cash_flow (annual, 2025-12-31) — Changes In Cash: -124119000.00
UCB cash_flow (quarterly, 2025-12-31) — Changes In Cash: -217677000.00
UCB balance_sheet (annual, 2025-12-31) — Common Stock: 120598000.00
UCB balance_sheet (quarterly, 2025-12-31) — Common Stock: 120598000.00
UCB cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -118518000.00
UCB cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -30841000.00
UCB balance_sheet (annual, 2025-12-31) — Common Stock Equity: 3638686000.00
UCB balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 3638686000.00
UCB cash_flow (annual, 2025-12-31) — Common Stock Payments: -44269000.00
UCB cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -30327000.00
UCB balance_sheet (annual, 2025-12-31) — Construction In Progress: 9016000.00
UCB balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 9016000.00
UCB cash_flow (annual, 2025-12-31) — Deferred Income Tax: 10145000.00
UCB cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 8025000.00
UCB cash_flow (annual, 2025-12-31) — Deferred Tax: 10145000.00
UCB cash_flow (quarterly, 2025-12-31) — Deferred Tax: 8025000.00
UCB cash_flow (annual, 2025-12-31) — Depreciation: 45951000.00
UCB cash_flow (quarterly, 2025-12-31) — Depreciation: 11841000.00
UCB cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 45951000.00
UCB cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 11841000.00
UCB income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 13079000.00
UCB income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 3188000.00
UCB cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 45951000.00
UCB cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 11841000.00
UCB income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 13079000.00
UCB income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 3188000.00
UCB balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 52997000.00
UCB balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 52997000.00
UCB income_statement (annual, 2025-12-31) — Diluted Average Shares: 121437000.00
UCB income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 121831000.00
UCB income_statement (annual, 2025-12-31) — Diluted EPS: 2.62
UCB income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.70
UCB income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 318183000.00
UCB income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 85893000.00
UCB cash_flow (annual, 2025-12-31) — End Cash Position: 395754000.00
UCB cash_flow (quarterly, 2025-12-31) — End Cash Position: 395754000.00
UCB cash_flow (annual, 2025-12-31) — Financing Cash Flow: -541571000.00
UCB cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -232986000.00
UCB cash_flow (annual, 2025-12-31) — Free Cash Flow: 356456000.00
UCB cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 59713000.00
UCB cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -352000.00
UCB cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -11000.00
UCB income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 8473000.00
UCB income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 2217000.00
UCB balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -150572000.00
UCB balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -150572000.00
UCB income_statement (annual, 2025-12-31) — General And Administrative Expense: 373438000.00
UCB income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 97274000.00
UCB balance_sheet (annual, 2025-12-31) — Goodwill: 925119000.00
UCB balance_sheet (quarterly, 2025-12-31) — Goodwill: 925119000.00
UCB balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 967882000.00
UCB balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 967882000.00
UCB balance_sheet (annual, 2025-12-31) — Gross PPE: 580245000.00
UCB balance_sheet (quarterly, 2025-12-31) — Gross PPE: 580245000.00
UCB balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 2236856000.00
UCB balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 2236856000.00
UCB income_statement (annual, 2025-12-31) — Insurance And Claims: 18987000.00
UCB income_statement (quarterly, 2025-12-31) — Insurance And Claims: 4754000.00
UCB income_statement (annual, 2025-12-31) — Interest Expense: 473832000.00
UCB income_statement (quarterly, 2025-12-31) — Interest Expense: 108441000.00
UCB income_statement (annual, 2025-12-31) — Interest Income: 1382939000.00
UCB income_statement (quarterly, 2025-12-31) — Interest Income: 346367000.00
UCB balance_sheet (annual, 2025-12-31) — Invested Capital: 3759086000.00
UCB balance_sheet (quarterly, 2025-12-31) — Invested Capital: 3759086000.00
UCB cash_flow (annual, 2025-12-31) — Investing Cash Flow: 33417000.00
UCB cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -50163000.00
UCB balance_sheet (annual, 2025-12-31) — Investments And Advances: 5988219000.00
UCB balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 5988219000.00
UCB cash_flow (annual, 2025-12-31) — Issuance Of Debt: 126000000.00
UCB cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
UCB balance_sheet (annual, 2025-12-31) — Land And Improvements: 126882000.00
UCB balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 126882000.00
UCB balance_sheet (annual, 2025-12-31) — Long Term Debt: 120400000.00
UCB balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 120400000.00
UCB balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 120400000.00
UCB balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 120400000.00
UCB cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 126000000.00
UCB cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
UCB cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -261000000.00
UCB cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -35000000.00
UCB balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 135537000.00
UCB balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 135537000.00
UCB cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 41246000.00
UCB cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
UCB cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -44269000.00
UCB cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -30327000.00
UCB income_statement (annual, 2025-12-31) — Net Income: 328095000.00
UCB income_statement (quarterly, 2025-12-31) — Net Income: 86455000.00
UCB income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 318183000.00
UCB income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 85893000.00
UCB income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 328095000.00
UCB income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 86455000.00
UCB income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 328095000.00
UCB income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 86455000.00
UCB income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 328095000.00
UCB income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 86455000.00
UCB cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 328095000.00
UCB cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 86455000.00
UCB income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 328095000.00
UCB income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 86455000.00
UCB income_statement (annual, 2025-12-31) — Net Interest Income: 909107000.00
UCB income_statement (quarterly, 2025-12-31) — Net Interest Income: 237926000.00
UCB cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 935002000.00
UCB cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 177941000.00
UCB cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -245000000.00
UCB cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 50000000.00
UCB cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -135000000.00
UCB cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -35000000.00
UCB cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -1222000.00
UCB cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -447000.00
UCB cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 18851000.00
UCB cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 2117000.00
UCB balance_sheet (annual, 2025-12-31) — Net PPE: 393714000.00
UCB balance_sheet (quarterly, 2025-12-31) — Net PPE: 393714000.00
UCB cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -27579000.00
UCB cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -5759000.00
UCB cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: -91541000.00
UCB cash_flow (quarterly, 2025-12-31) — Net Preferred Stock Issuance: 0.00
UCB cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -110000000.00
UCB cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 85000000.00
UCB balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 2670804000.00
UCB balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 2670804000.00
UCB income_statement (annual, 2025-12-31) — Normalized Income: 336023508.00
UCB income_statement (quarterly, 2025-12-31) — Normalized Income: 86919968.58
UCB income_statement (annual, 2025-12-31) — Occupancy And Equipment: 100212000.00
UCB income_statement (quarterly, 2025-12-31) — Occupancy And Equipment: 25878000.00
UCB cash_flow (annual, 2025-12-31) — Operating Cash Flow: 384035000.00
UCB cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 65472000.00
UCB cash_flow (annual, 2025-12-31) — Operating Gains Losses: -7507000.00
UCB cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -1390000.00
UCB income_statement (annual, 2025-12-31) — Operating Revenue: 1040952000.00
UCB income_statement (quarterly, 2025-12-31) — Operating Revenue: 272809000.00
UCB balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 120598266.00
UCB balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 120598266.00
UCB balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -150572000.00
UCB balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -150572000.00
UCB balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 42763000.00
UCB balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 42763000.00
UCB income_statement (annual, 2025-12-31) — Other Non Interest Expense: 38601000.00
UCB income_statement (quarterly, 2025-12-31) — Other Non Interest Expense: 9960000.00
UCB balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 2919740000.00
UCB balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 2919740000.00
UCB income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 5193000.00
UCB income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 3837000.00
UCB balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
UCB balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
UCB cash_flow (annual, 2025-12-31) — Preferred Stock Dividend Paid: -4719000.00
UCB cash_flow (quarterly, 2025-12-31) — Preferred Stock Dividend Paid: 0.00
UCB income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 4719000.00
UCB income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: -3275000.00
UCB cash_flow (annual, 2025-12-31) — Preferred Stock Payments: -91541000.00
UCB cash_flow (quarterly, 2025-12-31) — Preferred Stock Payments: 0.00
UCB income_statement (annual, 2025-12-31) — Pretax Income: 422412000.00
UCB income_statement (quarterly, 2025-12-31) — Pretax Income: 112678000.00
UCB income_statement (annual, 2025-12-31) — Professional Expense And Contract Services Expense: 24595000.00
UCB income_statement (quarterly, 2025-12-31) — Professional Expense And Contract Services Expense: 6773000.00
UCB cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
UCB cash_flow (annual, 2025-12-31) — Purchase Of Investment: -526841000.00
UCB cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -205443000.00
UCB cash_flow (annual, 2025-12-31) — Purchase Of PPE: -27579000.00
UCB cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -5759000.00
UCB balance_sheet (annual, 2025-12-31) — Receivables: 83557000.00
UCB balance_sheet (quarterly, 2025-12-31) — Receivables: 83557000.00
UCB income_statement (annual, 2025-12-31) — Reconciled Depreciation: 45951000.00
UCB income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 11841000.00
UCB cash_flow (annual, 2025-12-31) — Repayment Of Debt: -261000000.00
UCB cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 160000000.00
UCB cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -135810000.00
UCB cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -30327000.00
UCB income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 10204000.00
UCB income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 606000.00
UCB balance_sheet (annual, 2025-12-31) — Retained Earnings: 914261000.00
UCB balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 914261000.00
UCB income_statement (annual, 2025-12-31) — Salaries And Wages: 354451000.00
UCB income_statement (quarterly, 2025-12-31) — Salaries And Wages: 92520000.00
UCB cash_flow (annual, 2025-12-31) — Sale Of Business: 41246000.00
UCB cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
UCB cash_flow (annual, 2025-12-31) — Sale Of Investment: 1461843000.00
UCB cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 383384000.00
UCB income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 9605000.00
UCB income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 2790000.00
UCB income_statement (annual, 2025-12-31) — Selling General And Administration: 383043000.00
UCB income_statement (quarterly, 2025-12-31) — Selling General And Administration: 100064000.00
UCB balance_sheet (annual, 2025-12-31) — Share Issued: 120598266.00
UCB balance_sheet (quarterly, 2025-12-31) — Share Issued: 120598266.00
UCB income_statement (annual, 2025-12-31) — Special Income Charges: -10204000.00
UCB income_statement (quarterly, 2025-12-31) — Special Income Charges: -606000.00
UCB cash_flow (annual, 2025-12-31) — Stock Based Compensation: 11405000.00
UCB cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 3228000.00
UCB balance_sheet (annual, 2025-12-31) — Stockholders Equity: 3638686000.00
UCB balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 3638686000.00
UCB balance_sheet (annual, 2025-12-31) — Tangible Book Value: 2670804000.00
UCB balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 2670804000.00
UCB income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -2275492.00
UCB income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -141031.42
UCB income_statement (annual, 2025-12-31) — Tax Provision: 94317000.00
UCB income_statement (quarterly, 2025-12-31) — Tax Provision: 26223000.00
UCB income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.22
UCB income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.23
UCB balance_sheet (annual, 2025-12-31) — Total Assets: 28002554000.00
UCB balance_sheet (quarterly, 2025-12-31) — Total Assets: 28002554000.00
UCB balance_sheet (annual, 2025-12-31) — Total Capitalization: 3759086000.00
UCB balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 3759086000.00
UCB balance_sheet (annual, 2025-12-31) — Total Debt: 120400000.00
UCB balance_sheet (quarterly, 2025-12-31) — Total Debt: 120400000.00
UCB balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 3638686000.00
UCB balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 3638686000.00
UCB balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 24363868000.00
UCB balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 24363868000.00
UCB income_statement (annual, 2025-12-31) — Total Unusual Items: -10204000.00
UCB income_statement (quarterly, 2025-12-31) — Total Unusual Items: -606000.00
UCB income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -10204000.00
UCB income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -606000.00
UCB income_statement (quarterly, 2026-03-31) — +Total Revenue: 270369000.00
UCB balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 2721132000.00
UCB income_statement (quarterly, 2026-03-31) — Amortization: 3063000.00
UCB income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 3063000.00
UCB income_statement (quarterly, 2026-03-31) — Basic Average Shares: 120498000.00
UCB income_statement (quarterly, 2026-03-31) — Basic EPS: 0.69
UCB cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 395754000.00
UCB cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -6924000.00
UCB balance_sheet (quarterly, 2026-03-31) — Capital Stock: 119684000.00
UCB balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 493141000.00
UCB balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 493141000.00
UCB cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -30589000.00
UCB balance_sheet (quarterly, 2026-03-31) — Cash Financial: 177025000.00
UCB cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 73646000.00
UCB cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -45540000.00
UCB cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 69281000.00
UCB cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 10322000.00
UCB cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -61397000.00
UCB cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 10322000.00
UCB cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -53051000.00
UCB cash_flow (quarterly, 2026-03-31) — Changes In Cash: 97387000.00
UCB balance_sheet (quarterly, 2026-03-31) — Common Stock: 119684000.00
UCB cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -30589000.00
UCB balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 3654666000.00
UCB cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -37093000.00
UCB balance_sheet (quarterly, 2026-03-31) — Current Debt: 0.00
UCB balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 0.00
UCB cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 6055000.00
UCB cash_flow (quarterly, 2026-03-31) — Deferred Tax: 6055000.00
UCB cash_flow (quarterly, 2026-03-31) — Depreciation: 19819000.00
UCB cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 19819000.00
UCB income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 3063000.00
UCB cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 19819000.00
UCB income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 3063000.00
UCB balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 49475000.00
UCB income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 120723000.00
UCB income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.69
UCB income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 83737000.00
UCB cash_flow (quarterly, 2026-03-31) — End Cash Position: 493141000.00
UCB cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 73646000.00
UCB cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 62357000.00
UCB cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -133000.00
UCB income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 3502000.00
UCB balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -154338000.00
UCB income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 103518000.00
UCB balance_sheet (quarterly, 2026-03-31) — Goodwill: 925119000.00
UCB balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 964819000.00
UCB balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 2211523000.00
UCB income_statement (quarterly, 2026-03-31) — Insurance And Claims: 2269000.00
UCB income_statement (quarterly, 2026-03-31) — Interest Expense: 101197000.00
UCB income_statement (quarterly, 2026-03-31) — Interest Income: 333961000.00
UCB balance_sheet (quarterly, 2026-03-31) — Invested Capital: 3775166000.00
UCB cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -45540000.00
UCB balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 5889453000.00
UCB cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 475000000.00
UCB balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 120500000.00
UCB balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 120500000.00
UCB cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 475000000.00
UCB cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -475000000.00
UCB cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -37093000.00
UCB income_statement (quarterly, 2026-03-31) — Net Income: 84289000.00
UCB income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 83737000.00
UCB income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 84289000.00
UCB income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 84289000.00
UCB income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 84289000.00
UCB cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 84289000.00
UCB income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 84289000.00
UCB income_statement (quarterly, 2026-03-31) — Net Interest Income: 232764000.00
UCB cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 195310000.00
UCB cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -85000000.00
UCB cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 0.00
UCB cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -283000.00
UCB cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 2852000.00
UCB balance_sheet (quarterly, 2026-03-31) — Net PPE: 391883000.00
UCB cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -6924000.00
UCB cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -85000000.00
UCB balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 2689847000.00
UCB income_statement (quarterly, 2026-03-31) — Normalized Income: 84968194.00
UCB income_statement (quarterly, 2026-03-31) — Occupancy And Equipment: 25827000.00
UCB cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 69281000.00
UCB cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -2026000.00
UCB income_statement (quarterly, 2026-03-31) — Operating Revenue: 270369000.00
UCB balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 119684031.00
UCB balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 0.00
UCB balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -154338000.00
UCB balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 39700000.00
UCB income_statement (quarterly, 2026-03-31) — Other Non Interest Expense: 9907000.00
UCB balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 3574546000.00
UCB income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 552000.00
UCB cash_flow (quarterly, 2026-03-31) — Preferred Stock Dividend Paid: 0.00
UCB income_statement (quarterly, 2026-03-31) — Pretax Income: 108355000.00
UCB income_statement (quarterly, 2026-03-31) — Professional Expense And Contract Services Expense: 5576000.00
UCB cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -80226000.00
UCB cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -6924000.00
UCB income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 19819000.00
UCB cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -560000000.00
UCB cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -37093000.00
UCB income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 873000.00
UCB balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 968188000.00
UCB income_statement (quarterly, 2026-03-31) — Salaries And Wages: 101249000.00
UCB cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 275536000.00
UCB income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 2397000.00
UCB income_statement (quarterly, 2026-03-31) — Selling General And Administration: 105915000.00
UCB balance_sheet (quarterly, 2026-03-31) — Share Issued: 119684031.00
UCB cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: -85000000.00
UCB income_statement (quarterly, 2026-03-31) — Special Income Charges: -873000.00
UCB cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 3342000.00
UCB balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 3654666000.00
UCB balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 2689847000.00
UCB income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -193806.00
UCB income_statement (quarterly, 2026-03-31) — Tax Provision: 24066000.00
UCB income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.22
UCB balance_sheet (quarterly, 2026-03-31) — Total Assets: 28176582000.00
UCB balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 3775166000.00
UCB balance_sheet (quarterly, 2026-03-31) — Total Debt: 120500000.00
UCB balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 3654666000.00
UCB balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 24521916000.00
UCB income_statement (quarterly, 2026-03-31) — Total Unusual Items: -873000.00
UCB income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -873000.00
UCB balance_sheet (quarterly, 2026-03-31) — Trading Securities: 103384000.00
UCB income_statement (quarterly, 2026-06-30) — Basic Average Shares: 120303000.00
UCB income_statement (quarterly, 2026-06-30) — Basic EPS: 0.95
UCB income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 120442000.00
UCB income_statement (quarterly, 2026-06-30) — Diluted EPS: 0.95
UCB.BR income_statement (annual, 2021-12-31) — Basic EPS: 5.60
UCB.BR cash_flow (annual, 2021-12-31) — Common Stock Issuance: 0.00
UCB.BR income_statement (annual, 2021-12-31) — Diluted Average Shares: 194177000.00
UCB.BR income_statement (annual, 2021-12-31) — Diluted EPS: 5.45
UCB.BR cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 0.00
UCB.BR balance_sheet (annual, 2021-12-31) — Net Debt: 725000000.00
UCB.BR cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 15000000.00
UCB.BR cash_flow (annual, 2021-12-31) — Other Cash Adjustment Outside Changein Cash: 1000000.00
UCB.BR balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 1000000.00
UCB.BR cash_flow (annual, 2021-12-31) — Sale Of PPE: 1000000.00
UCB.BR income_statement (annual, 2022-12-31) — +Operating Expense: 3141000000.00
UCB.BR income_statement (annual, 2022-12-31) — +Total Revenue: 5517000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Accounts Payable: 573000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Accounts Receivable: 687000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1273000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 2030000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -15000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 0.00
UCB.BR balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 150000000.00
UCB.BR income_statement (annual, 2022-12-31) — Basic Average Shares: 189619000.00
UCB.BR income_statement (annual, 2022-12-31) — Basic EPS: 2.20
UCB.BR cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1244000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Capital Expenditure: -371000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 140000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Capital Stock: 584000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 899000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 1142000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -247000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Cash Equivalents: 696000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Cash Financial: 203000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Change In Inventory: -93000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -65000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Change In Payable: -173000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Change In Receivables: 162000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Change In Working Capital: -169000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Changes In Cash: -391000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -247000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Common Stock Equity: 9064000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Common Stock Payments: -42000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Construction In Progress: 541000000.00
UCB.BR income_statement (annual, 2022-12-31) — Cost Of Revenue: 1675000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Current Assets: 3304000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 40000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Current Debt: 222000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 262000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Current Liabilities: 3112000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Current Provisions: 191000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Deferred Tax: 91000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 24000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Depreciation: 589000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 589000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 99000000.00
UCB.BR income_statement (annual, 2022-12-31) — Diluted Average Shares: 194834000.00
UCB.BR income_statement (annual, 2022-12-31) — Diluted EPS: 2.14
UCB.BR income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 418000000.00
UCB.BR income_statement (annual, 2022-12-31) — EBIT: 582000000.00
UCB.BR income_statement (annual, 2022-12-31) — EBITDA: 1171000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 6000000.00
UCB.BR cash_flow (annual, 2022-12-31) — End Cash Position: 859000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Financial Assets: 28000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Financing Cash Flow: 70000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Finished Goods: 185000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Free Cash Flow: 748000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -1000000.00
UCB.BR income_statement (annual, 2022-12-31) — General And Administrative Expense: 225000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Goodwill: 5340000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 10156000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 702000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Gross PPE: 2707000000.00
UCB.BR income_statement (annual, 2022-12-31) — Gross Profit: 3842000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 123000000.00
UCB.BR income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 2000000.00
UCB.BR income_statement (annual, 2022-12-31) — Interest Expense: 71000000.00
UCB.BR income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 71000000.00
UCB.BR income_statement (annual, 2022-12-31) — Interest Income: 12000000.00
UCB.BR income_statement (annual, 2022-12-31) — Interest Income Non Operating: 12000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Interest Paid Cff: -74000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Interest Received Cfo: 28000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Inventory: 907000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Invested Capital: 11824000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1580000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 150000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Issuance Of Debt: 1025000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 100000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Long Term Debt: 2538000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 2638000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 1025000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -546000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Long Term Provisions: 171000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1263000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Minority Interest: 0.00
UCB.BR income_statement (annual, 2022-12-31) — Minority Interests: 0.00
UCB.BR cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -1212000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -42000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Net Debt: 1861000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 84000000.00
UCB.BR income_statement (annual, 2022-12-31) — Net Income: 418000000.00
UCB.BR income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 418000000.00
UCB.BR income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 420000000.00
UCB.BR income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: -2000000.00
UCB.BR income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 418000000.00
UCB.BR income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 420000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 418000000.00
UCB.BR income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 418000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -119000000.00
UCB.BR income_statement (annual, 2022-12-31) — Net Interest Income: -64000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 2000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 479000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 479000000.00
UCB.BR income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -64000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 1000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Net PPE: 1434000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -252000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -1092000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 756000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 377000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 162000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 16000000.00
UCB.BR income_statement (annual, 2022-12-31) — Normalized EBITDA: 1273000000.00
UCB.BR income_statement (annual, 2022-12-31) — Normalized Income: 503640000.00
UCB.BR cash_flow (annual, 2022-12-31) — Operating Cash Flow: 1119000000.00
UCB.BR income_statement (annual, 2022-12-31) — Operating Income: 701000000.00
UCB.BR income_statement (annual, 2022-12-31) — Operating Revenue: 5517000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 189594898.00
UCB.BR balance_sheet (annual, 2022-12-31) — Other Current Assets: -1000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 4816000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Other Non Cash Items: 129000000.00
UCB.BR income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -51000000.00
UCB.BR income_statement (annual, 2022-12-31) — Other Operating Expenses: 13000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Other Payable: 1165000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Other Receivables: 192000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 243000000.00
UCB.BR income_statement (annual, 2022-12-31) — Other Special Charges: -1000000.00
UCB.BR income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
UCB.BR balance_sheet (annual, 2022-12-31) — Payables: 1803000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Prepaid Assets: 140000000.00
UCB.BR income_statement (annual, 2022-12-31) — Pretax Income: 511000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Properties: 903000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 73000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Purchase Of Business: -1212000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -119000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Purchase Of Investment: -17000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Purchase Of PPE: -252000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Raw Materials: 121000000.00
UCB.BR income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 1675000000.00
UCB.BR income_statement (annual, 2022-12-31) — Reconciled Depreciation: 589000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Repayment Of Debt: -546000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -42000000.00
UCB.BR income_statement (annual, 2022-12-31) — Research And Development: 1670000000.00
UCB.BR income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 42000000.00
UCB.BR balance_sheet (annual, 2022-12-31) — Retained Earnings: 6445000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
UCB.BR cash_flow (annual, 2022-12-31) — Sale Of Investment: 19000000.00
UCB.BR cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
UCB.BR income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 1489000000.00